Generic Route/Dose/ Mechanis Indication Contra- Adverse Nursing Responsibilities

name Frequency m of s indications Reaction

Action DRUG STUDY Common 1. Checkthe patient's medical
ADULT Albuterol acts  Reversible  Hypersensitivity adverse record for an allergy or
ALBUTEROL on beta-2 obstructive to albuterol reactions contraindication to the prescribed
SULFATE  Powder adrenergic airway  Severe include: medication.
(SALBUTAMOL) metered-dose receptors to disease hypersensitivity  Palpitations 2. Assess lung sounds, pulse, and
inhaler relax the (chronic to milk proteins  Headaches BP before administration and
bronchial asthma,  Use cautiously in  Throat during peak of medication. Note
180 mcg (2 puffs) smooth muscle. bronchitis) patients with CV irritation amount, color, character of
inhaled PO q4-6hr; It also inhibits disorders  Tremors sputum produced.
not to exceed 12 the release of Inhalation: (including  Nervousness 3. Monitor pulmonary function test
Classification inhalations/24 hr immediate  Treatment coronary  Restlessness before initiating therapy and
hypersensitivity of acute insufficiency and  Tachycardia periodically throughout course to
Sympathomime  Aerosol mediators from attacks of hypertension),hy determine effectiveness of
tic, Beta2- metered-dose cells, especially bronchosp perthyroidism,or Less common
medication.
selective inhaler mast cells. asm diabetes mellitus. adverse 4. If able, teach patient how to
adrenergic 180 mcg (2 puffs)  Prevention reactions used metered dose inhaler by
agonist, inhaled PO q4-6hr; of exercise- include: instructing him/her to tilt his/her
Bronchodilator, not to exceed 12 induced head back slightly and inhale
Antiasthmatic inhalations/24hr bronchosp  Insomnia slowly and deeply.
asm  dry mouth. 5. Observe paradoxical
 Tablet and bronchospasm or wheezing. If
syrup Uncommon condition occurs, withhold
Adult: 2-4 mg PO adverse effects medication and notify physician
q6-8hr; not to include: immediately.
exceed 32 mg/day  chest pain 6. Instruct patient to take missed
 paradoxical dose as soon as remembered,
 Nebulizer bronchospas spacing remaining doses at regular
solution m intervals.
2.5 mg BID/TID  allergic 7. Inform patient not to smoke and
PRN; 1.25 - 5 mg reactions avoid respiratory irritants.
q4-8hr PRN for 8. Advice patient to rinse his/her
quick relief mouth with water or use of sugar-
 Generic name Route/Dose/ Mechanism Indication Contraindications Adverse Nursing
Frequency of Action Reaction Responsibilities

IPRATROPIUM Available forms :

DRUG STUDY
Ipratropium is
an acetylcholine
 Managemen
t of
 Bromide
hypersensitivity
 Bronchitis
 COPD
1. Check the patient's
medical record for an allergy
BROMIDE Aerosol—18 antagonist via reversible  With exacerba or contraindication to the
mcg/actuation; blockade of bronchospas hypersensitivity to tion prescribed medication.
solution for muscarinic m associated soya lecithin or  Dyspnea 2. Assess lung sounds, pulse,
inhalation—0.02% cholinergic by chronic related food  Headache and BP before
(500 mcg/vial); receptors. obstructive products such as  Throa administration and during
Classification nasal spray— Blocking pulmonary soybean and  Irritation peak of medication. Note
0.03% (21 cholinergic disease peanut  Cough amount, color, character of
Anticholinergic, mcg/spray), receptors (COPD)  paradoxical  dry sputum produced.
Antimuscarinic, 0.06% (42 decreases the  Rhinorrhea bronchospasm mouth 3. Monitor pulmonary
Parasympatholytic mcg/spray) production of due to  Closed-angle  gastro- function test before
cyclic guanosine seasonal glaucoma, contact intestinal initiating therapy and
 Adults monophosphat allergies or lenses, ocular motility periodically throughout
136 mcg (8 e (cGMP). This the common exposure, disorders course to determine
actuations of 17 decrease in the cold ophthalmic (including effectiveness of medication.
mcg/actuation) lung airways will  Exercise- administration constipati 4. Use nebulizer mouthpiece
via oral inhalation lead to induced  Bladder on, instead of face mask to
every 20 minutes decreased bronchospas obstruction, diarrhea avoid blurred vision or
as needed for up contraction of m prostatic and aggravation of narrow-angle
to 3 hours the smooth prophylaxis hypertrophy, vomiting) glaucoma.
muscles.  Asthma urinary retention  Nausea 5. Have patient void before
 Children 6 to exacerbation  Cardiac  dizziness. taking medication to avoid
12 years arrhythmias urinary retention.
68 to 136 mcg (4  Tachyarrhythmia 6. Teach patient proper use
to 8 actuations of  Pregnancy and of inhaler.
17 mcg/actuation) lactation 7. Inform patient not to
via oral inhalation smoke and avoid respiratory
every 20 minutes irritants.
as needed for up 8. Advice patient to rinse
to 3 hours his/her mouth with water or
use of sugar-free gum after
 Generic
Genericname Route/Dose
Route/Dose Mechanism
Mechanism of of Indication
IndicationContraindicationContra- Adverse
Adverse Nursing
Nursing
name / / Action
Action s
indications Reaction
Reaction Responsibilitie
Responsibilities
Frequency
Frequency DRUG STUDY
 Prophylaxis  Hypersensitivity
 Not for use  GI 1. Check
1. Check
s
thethepatient's
patient's
BECLOMETHASONE
ZAFIRLUKAST Available
 Nasal Zafirlukast
Beclometasone and
 Prophylaxis
long-  and hepaticduring an disturbances
 Loss of skinmedical
medical record
recordfor for
an an
forms
Adult:
: 100 mcg
selectively
controls the rate of termtreatment of impairment
attack  Headache
collagen andallergy
allergy or or
bid or 50 mcg antagonizes
3- protein synthesis,
the treatment
allergic and nonCirrhosis
 Hypersensitivit  Myalgia
SC atrophy contraindication
contraindication to the
to the
Tablet—10,
4 times daily
20 leukotriene
in depresses D4 the of bronchialallergic rhinitis
 acute y asthmatic  generalized
 local prescribed
prescribed medication.
medication.
mg each nostril.
receptor.
migration
It inhibits of asthma
 Severein asthmaattack active painhypopigmenta2. Assess
2. Assessvitalweight,
signs. temp,
Classification Max: 400 mcg bronchoconstrictio
polymorphonuclea adults  Respiratory
and  Pregnancy tuberculosis
and &  Fever
tion of deeply3. Administer
Pulse, BP, auscultation;
on an
Antasthmatic,  ADULTS
daily. n caused
r by various
leukocytes, children
inhalant
> 5 use: Lactation
inactive  Dizziness
pigmented empty R, adventitious
stomach 1sounds; hr
Leukotriene
Classification AND inhaled
fibroblasts,
antigens or yr Control of tuberculosis  raised
 skin;
LFT
dryness before
chestor radiograph
2 hr after before
receptor CHILDREN
 Inhalation> irritants.
reverses
It is capillary
not  Unlabeled
bronchial  herpes simplex  respiratory
 Irritation meals.
respiratory inhalant
Corticosteroid,
antagonist 12
Adult:
YR Initially,
usedpermeability
in acute and use:asthma
Chronic that infection of the tractEpistaxis
 infections 4. Ensure
therapy.that drug is
Glucocorticoid 20 600-800
mg PO bidmcg asthma
lysosomal
attacks. urticaria
requires eye  hypersensitivit
 rarely taken
3. BLACK
continually forBOX
Hormone on daily. an empty stabilisation at the corticosteroids  a nasal fungal y reactions
ulceration oroptimal
WARNING
effect.
stomach
Child: 50 or 100 cellular level to along with infection due  Churg-Strauss
perforation of5. WARNING:
4. Use decongestant
Do not
mcg bid-qid or prevent or control other therapy to Candida syndrome
the nasaladminister
nose drops forto acute
facilitate
 PEDIATRIC
100 or 200 mcg inflammation.  Intranasal use:  an infection
 Potentially
septum asthma
penetration
attack or acute of
PATIENTS
bid. Relief of due to a Fatal:
 smellSevereandbronchospasm.
intranasal steroids if
5–11 YR symptoms of parasite hepatotoxicity
taste 6. Advice
edema patientor excessive
to
10 Severe
mg POasthma
bid seasonal or  decreased disturbances avoidsecretions
use of areover-the-
present.
on Adult:
an empty
250 mcg perennial function of the  hoarseness counter 5. Allow medications
patient at least
stomach.
four times daily rhinitis that adrenal gland. and while
1 minute
using this
between
drug as puffs
or 500 mcg bid. respond poorly  increased candidiasis ofmany(respiratory
of them inhalant);
contain if
May be to other pressure in the the mouth orproducts
patient isthatalso using
can an
increased to 500 treatments; eye. throat interfere
inhalational
with drug or
mcg 3-4 times prevention of  wide-angle cause
bronchodilator
serious side
daily if recurrence of glaucomacloud effects.
(isoproterenol,
necessary. Max: nasal polyps ing of the lens 7. Advise
albuterol,patient or
2 mg daily. following of the eye significant
metaproterenol,
others to
surgical called report
epinephrine).
any adverse
removal cataracts effects.
6. Inform patient not to
 ulcers of the smoke and avoid
nasal septum respiratory irritants.